These differences may be at the level of surface expression of distinct integrin pairs (which have been shown to act as receptors for Mindin on macrophages, T cells, and colorectal cancer) (40, 41, 71) and/or different cytoplasmic machinery downstream of the receptors. Here, SPON2 is linked to colorectal cancer.